Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients
- 1 January 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pain
- Vol. 153 (1), 142-148
- https://doi.org/10.1016/j.pain.2011.10.003
Abstract
De pain relief and facilitate intensive care therapies. Iatrogenic withdrawal syndrome occurs when these drugs are stopped abruptly or weaned too rapidly. We investigated the validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) in children during weaning of analgesics and sedatives. Of 308 children initially supported on mechanical ventilation for acute respiratory failure, 126 (41%) from 21 centers (median age 1.6 years; interquartile range 0.6–7.7 years) were exposed to 5 or more days of opioids. Subjects were assessed for withdrawal symptoms with the WAT-1, an 11-item (12-point) scale, from the first day of weaning from analgesia/sedation until 72 h after the last opioid dose. A total of 836 daily WAT-1 assessments were completed, with a median (interquartile range) WAT-1 score of 2 (0–4) over 6 (3–9) days per subject. There were no significant differences in WAT-1 scores as a function of age. Factor analyses confirmed that motor-related symptoms and behavioral state accounted for the most variance in WAT-1 scores. Supporting construct validity, cumulative opioid exposures were greater [40.2 (19.7–83.4) vs 17.6 (14.6–39.7) mg/kg, P = .004], length of opioid treatment before weaning was longer [7 (6–11) vs 5 (5–8) days, P = .004], and length of weaning from opioids was longer [10 (6–14) vs 6 (3–9) days, P = .008] in subjects with WAT-1 scores of ≥3 compared to subjects with WAT-1 scores of <3. The WAT-1 shows good psychometric performance and generalizability when used to assess clinically important withdrawal symptoms in pediatric intensive care and general ward settings....Keywords
This publication has 26 references indexed in Scilit:
- Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill ChildrenPediatrics, 2010
- Pharmacology of Commonly Used Analgesics and Sedatives in the ICU: Benzodiazepines, Propofol, and OpioidsCritical Care Clinics, 2009
- The Withdrawal Assessment Tool–1 (WAT–1): An assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients*Pediatric Critical Care Medicine, 2008
- Minimizing Tolerance and Withdrawal to Prolonged Pediatric Sedation: Case Report and Review of the LiteratureJournal of Intensive Care Medicine, 2007
- Current United Kingdom sedation practice in pediatric intensive carePediatric Anesthesia, 2007
- Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patientsIntensive and Critical Care Nursing, 2004
- Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: Survey of fellowship training programs*Pediatric Critical Care Medicine, 2004
- PRISM IIICritical Care Medicine, 1996
- Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusionCritical Care Medicine, 1994
- Assessing the outcome of pediatric intensive careThe Journal of Pediatrics, 1992